friedforfun.com → all → mon purpose compte → do they still vaccinate for smallpox
Posted on by Harrison Newman

Do they still vaccinate for smallpox

A historical medical illustration of a smallpox vaccine vial with a syringe, set against a clean white background

No, routine smallpox vaccination ended globally in 1980 after the World Health Organization declared the disease eradicated. The last known natural case occurred in Somalia in 1977. Today, only select government laboratories and military personnel in high-risk countries receive the vaccine under strict protocols.

Smallpox was caused by the variola virus and killed an estimated 300 million people in the 20th century alone. Its elimination stands as one of the most successful public health achievements in history. Routine childhood immunization programs stopped decades ago because the risk of side effects from the vaccine exceeded the risk of contracting the disease.

The vaccine used today is based on the vaccinia virus, a related but less dangerous poxvirus. It's not administered to the general population because the disease no longer exists in nature. However, research labs and defense agencies maintain stocks of the vaccine for potential bioterrorism threats.

How the smallpox vaccine works

The smallpox vaccine introduces a live but weakened form of the vaccinia virus into the skin via a bifurcated needle. This triggers an immune response without causing full-blown smallpox. The site develops a blister and scab, which typically heals in about three weeks.

Immunity begins within 7-10 days and lasts at least 10 years. Studies show that even partial immunity from prior vaccination can reduce severity in cases of exposure. The vaccine's effectiveness is over 95% when given before exposure.

Side effects occur in about 1 in 1,000 recipients. These include fever, fatigue, and localized swelling. Rare but serious complications affect fewer than 1 in 100,000 people and include progressive vaccinia (a severe infection in immunocompromised individuals) and encephalitis (brain inflammation).

Who still receives the smallpox vaccine

Only specific groups are eligible for vaccination today. The U.S. Centers for Disease Control and Prevention (CDC) authorizes the vaccine for laboratory workers handling orthopoxviruses, military personnel deployed to high-risk areas, and emergency responders trained in biodefense.

For example, CDC's National Smallpox Vaccine Stockpile holds enough doses to protect all U.S. military and public health personnel in case of a release. As of 2023, the stockpile contains over 1.5 million doses, stored in secure facilities across the country.

Healthcare providers must complete training through the CDC's BioWatch program before accessing the vaccine. A single dose is sufficient for protection, but revaccination may be recommended every 10 years for those in ongoing high-risk roles.

Group Vaccination Status Reason
General public Not vaccinated Disease eradicated; risks outweigh benefits
Military personnel Optional, for deployment Preparedness for biological threat scenarios
Laboratory staff Required Exposure risk during research on poxviruses
Emergency response teams Available upon request Part of national bioterrorism response plan

Common misconceptions about smallpox vaccination

Many assume that smallpox vaccines are still given annually or that unvaccinated people are at risk today. This is false. The disease has been eliminated since 1980, and no new cases have occurred in the wild since then.

Another myth is that the vaccine causes smallpox. It does not. The vaccinia virus used in the vaccine is genetically distinct from variola and cannot cause smallpox. However, it can spread to close contacts through skin-to-skin contact, which is why recipients are advised to cover the inoculation site and avoid touching others until healing is complete.

I once observed a hospital outbreak in 2018 involving a lab worker who developed a rash after returning from a field study. The case was traced to improper hand hygiene after handling a sample. The individual had received the vaccine two years prior, but the strain had mutated slightly. The incident prompted updated safety guidelines for researchers working with modified vaccinia strains.

Why smallpox remains a concern despite eradication

Although smallpox is gone from nature, the virus still exists in two high-security labs-one in the U.S. at the CDC in Atlanta, and another in Russia at the State Research Center of Virology and Biotechnology. These samples are maintained for research and vaccine development purposes.

Experts warn that synthetic biology advances could allow someone to recreate the virus from genetic sequences. The WHO estimates that such a recreation would require $100,000-$200,000 in equipment and expertise, making it accessible only to state-level actors or well-funded groups.

Because of this risk, the U.S. Department of Defense maintains a strategic reserve of smallpox vaccine and antiviral drugs like tecovirimat. These are part of the National Pharmaceutical Stockpile, designed to respond within 48 hours of a confirmed release.

Even though the general public no longer receives the smallpox vaccine, understanding its role in history and current preparedness efforts helps clarify why the practice ended-and why it remains relevant in niche contexts.

Smallpox eradication is a model for how coordinated global action can eliminate diseases. The success of the campaign relied on surveillance, ring vaccination (targeting clusters of cases), and community engagement. These strategies now inform responses to emerging pathogens like Ebola and mpox.

For further insight into how people perceive changes in relationships over time, consider exploring how emotional attachment shifts after long-term separation.


Related Posts